Gynecologic Cancer and Blood Clot Risk Study
Treatments studied
Part of Cancer, Heart & circulation, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at the risk of blood clots in women with gynecologic cancers who are starting a new line of cancer treatment. It aims to help doctors better predict and prevent blood clots in patients like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and 18 years or older
- You have been diagnosed with a gynecologic cancer (ovarian, tubal, uterine, cervical, vaginal, or vulvar cancer)
- You are about to start a new line of cancer treatment (chemotherapy, targeted therapy, etc.)
- You are not pregnant or breastfeeding
- You are not currently taking blood thinners for a condition like atrial fibrillation or a mechanical heart valve
- You do not have a symptomatic blood clot at the time of screening
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether doctors can predict blood clots in people with certain cancers who are receiving chemotherapy. If you have ovarian, lung, stomach, or pancreatic cancer and are starting chemotherapy, you may be able to join and help improve clot prevention.
This study looks at how well blood thinners (anticoagulants) work in people with cancer who have had a blood clot. It aims to compare the benefits and risks of different anticoagulant medicines.
This trial is testing a program to help prevent blood clots in people with cancer who are starting a new type of cancer treatment, like chemotherapy or targeted therapy. The goal is to see if better prevention strategies can keep you safe during treatment.
This study is for people with cancer who have had a serious blood clot. Researchers want to create a risk score that predicts who might have another clot or a bleeding problem from treatment, so they can better tailor care.
This study looks at tumor tissue and blood samples to find biological “markers” in people with gynecologic cancers. It may help researchers understand disease better and could guide future, more personalized treatments.
This trial tests a program to help people who had cancer surgery get medicine to prevent dangerous blood clots. If you had belly or pelvic cancer surgery and are not on blood thinners, you may be able to join.
Hear when a new Cancer-associated Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.